# S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer

> **NCT00057928** · PHASE3 · WITHDRAWN · sponsor: **SWOG Cancer Research Network**

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00057928
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2003-04
- **Primary completion:** 2003-07
- **Final completion:** 2003-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of accrual
- **Last updated:** 2012-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00057928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00057928, "S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00057928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*